| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-10 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-08 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.25 | 4e-06 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 5e-05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |